GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imunon Inc (FRA:CBO) » Definitions » 5-Year Yield-on-Cost %

Imunon (FRA:CBO) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 26, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Imunon 5-Year Yield-on-Cost %?

Imunon's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Imunon's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:CBO's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.66
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Imunon's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Imunon's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imunon's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Imunon's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Imunon's 5-Year Yield-on-Cost % falls into.


;
;

Imunon 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Imunon is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Imunon  (FRA:CBO) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Imunon 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Imunon's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Imunon Business Description

Traded in Other Exchanges
Address
997 Lenox Drive, Suite 100, Lawrenceville, NJ, USA, 08648
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

Imunon Headlines

No Headlines